Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1507 of 6351
-
Can a genetic hunt solve the mystery of a painful skin condition?
Knowledge-focused Recruiting nowLichen Sclerosus (LS) is a common genital skin condition that severely impacts on daily living. LS occurs worldwide but may be more common in the white population. The extragenital skin is involved in about 10% of reported patients, exact numbers are not known. LS is estimated to…
Sponsor: Gudula Kirtschig • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New hope for veterans with PTSD: personalized therapy and text reminders
Symptom relief Recruiting nowBy doing this research project, the investigators hope to learn which strategies work best to help veterans who are not benefiting from their first PTSD treatment or not completing between-session homework assignments regularly that might improve treatment response. The investiga…
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Microscopic blood vessel health may hold key to cardiogenic shock survival
Knowledge-focused Recruiting nowDespite advancements in treatment, the mortality rate for cardiogenic shock (CS) remains high at around 50%. The EMPULSE-HF trial showed that early introduction of empagliflozin in stabilized patients with acute heart failure led to a composite benefit in mortality, rehospitaliza…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Ancient acupressure meets modern medicine: can ear stimulation replace standard Anti-Nausea drugs?
Symptom relief Recruiting nowThis study aims to evaluate whether the preventive and suppressive effects of auricular point stimulation combined with dexamethasone on nausea and vomiting induced by the gemcitabine plus paclitaxel protein-bound regimen are non-inferior to the standard antiemetic regimen in pan…
Phase 3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
A surgical tweak may speed bladder control recovery after prostate removal
Symptom relief CompletedThis is a single-center prospective cohort study enrolling 60 to 100 patients with prostate cancer treated at The Cancer Hospital of the Chinese Academy of Medical Sciences between December 2025 and July 2026, who will receive modified RARP combined with anterior urethral suspens…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Smart home tech may keep elderly patients out of the hospital — a trial puts it to the test
Disease control Recruiting nowThe objective of the TRANSCARE study is to evaluate the use of a digital remote monitoring system to reduce the risk of 30-day readmission in multimorbid elderly patients. The pilot study is multicenter, and the trial will be conducted across 3 sites: Italy, Romania, and Norway. …
Sponsor: Istituto Nazionale di Ricovero e Cura per Anziani • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New spinal stimulator aims to ease pain after failed back surgery
Symptom relief Recruiting nowEvaluation of the effectiveness of differential target multiplexed spinal cord stimulation for treatment of Persistent Spinal Pain Syndrome Type II (PSPS-T2). Identification of clinical effective parameters concerning frequency, pulse duration, amplitude and battery consumption/r…
Sponsor: Universitair Ziekenhuis Brussel • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New immune therapy shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis is an early phase trial designed to evaluate the safety, tolerability, and preliminary antitumor activity of RPTR-1-201 in adults with advanced solid tumors. The trial includes dose escalation and dose expansion parts and will evaluate RPTR-1-201 as monotherapy and in combin…
Phase 1/2 • Sponsor: Repertoire Immune Medicines • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a simpler biopsy replace major surgery for inflammatory breast cancer?
Knowledge-focused Recruiting nowThis study will prospectively determine the feasibility and oncological safety of sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NACT) in inflammatory breast cancer patients traditionally considered ineligible for SLNB due to locally advanced cancer with skin/c…
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Blood test could replace gadolinium scans for MS monitoring
Knowledge-focused Recruiting nowReference MRI scan is recommended 6 months after treatment onset in patients with multiple sclerosis (MS), and follow-up scans at 12 months later to monitor subclinical activity. When monitoring treatment response in patients treated with disease modifying treatments (DMTs), the …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study monitors Real-World impact of secukinumab on painful skin condition
Disease control Recruiting nowThe HS-RISE study aims to assess real-world HS treatment outcomes and patterns, safety of secukinumab, and to describe the baseline characteristics of patients diagnosed with moderate-to- severe HS who are prescribed secukinumab in Canadian routine clinical practice.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New combo aims to boost Pre-Surgery treatment for stomach cancer
Disease control Recruiting nowWith this trial, we aim to evaluate a new combination therapy with tislelizumab and FLOT chemotherapy before surgery (neoadjuvant) for locally advanced, resectable adenocarcinoma of the esophagus or stomach (EGA). The aim of this phase Ib trial is to determine whether this combin…
Phase 1 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New shot targets tough blood cancers in early trial
Disease control Recruiting nowThis is a single-arm, open-label study designed to evaluate the safety, tolerability and cellular pharmacokinetic profiles of UTAA07 Injection. It also aims to preliminarily assess the efficacy of the investigational drug in subjects with relapsed/refractory hematolymphoid malign…
Early phase 1 • Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New shot aims to fortify fragile bones in brittle bone disease trial
Disease control Recruiting nowThis study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo.
Phase 2 • Sponsor: Angitia Incorporated Limited • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Ultrasound inside arteries could boost leg treatment success
Disease control Recruiting nowThis study will test whether using ultrasound imaging within blood vessels during minimally invasive treatment of leg arteries in patients with peripheral artery disease leads to better clinical outcomes.
Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Diabetes drug dapagliflozin tested to shield hearts during breast cancer treatment
Disease control Recruiting nowCardiotoxicity is heart damage that arises from certain drugs, such as those used for cancer treatment and develops in approximately 10% of patients with breast cancer who are treated with anthracyclines. It has been suggested that sodium-glucose transporter-2 (SGLT2) inhibitors …
Sponsor: University of Aberdeen • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New Botox-Like shot could loosen stiff arms in stroke survivors
Symptom relief Recruiting nowThis is a phase III clinical study to evaluate the efficacy and safety of recombinant botulinum toxin type A(Eveotox)in adult patients with upper limb spasticity. The purpose of this study was to observe efficacy and safety of Eveotox compared with placebo in adult patients with …
Phase 3 • Sponsor: JHM BioPharma (Tonghua) Co. , Ltd. • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Prune power: could 5 prunes a day save your bones?
Prevention Recruiting nowDietary interventions of prune consumption during the transmenopausal period are innovative methods to prevent bone loss. Modern medicine does not intervene to prevent or attenuate this highly vulnerable period of bone loss which, if successfully attenuated, can potentially preve…
Sponsor: Penn State University • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
New study tests biologic drug guselkumab for ulcerative colitis in chinese patients
Disease control Recruiting nowThe purpose of this study is to assess the measurable changes in health, function, or quality of life (clinical outcomes) after receiving guselkumab in real-world clinical practice amongst Chinese participants with ulcerative colitis (UC; a long-term disease of the large intestin…
Sponsor: Xian-Janssen Pharmaceutical Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Sound waves aim to quiet fibromyalgia pain
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four treatments over the course of one month and will complete surveys at multiple time …
Sponsor: SPIRE Therapeutics Inc. • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC